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Schistosomiasis due to Schistosoma mansoni is a snail-transmitted parasitic disease
that affects millions of individuals and is amajor concern for a number of subtrop-
ical countries (1) . Control by chemotherapy and mollusciciding is costly, may lead
to the emergenceof resistant strains of parasites, and requires well-trained personnel
who are seldom available in endemic areas (2-6); for these reasons, additional con-
trol methods are sought .
Immunological studies in laboratory animals have raised expectations that avac-
cine against S . mansoni could be produced . However, a major difficulty in developing
a vaccine against this parasite is that natural immunization schemes consisting of
repeated infections interrupted by chemotherapy fail to protect a sizeable fraction
of the population ofendemic areas (7-10) . The most susceptible individuals often
bear heavy infections andare at high risks ofdeveloping severe clinical disease (11-13);
they are also the principal reservoir of parasites. It is, therefore, most important to
identify the causes of the higher susceptibility of these individuals in order to define
the properties that a vaccine should have in order to protect them .
Since a number of studies indicated that antischistosomular IgG antibodies were
central to animal protection against S, mansoni (reviewed in reference 14), we have
evaluated the antilarval surface IgG antibody response of subjects with high orlow
susceptibilities to infection byS . mansont (10) . Subjects of both susceptibility hadcom-
parable levels of antilarval IgG; IgGfrom the sera ofthe majority (50-80%) of sub-
jects with low susceptibility reacted with three major larval surface antigens ofM,
165, 72, and37kD. Sera from50-80% ofthemost susceptible individuals also reacted
with the 165 and 72 antigens (Ag) ; ' most of them, however, failed to react with the
37 Ag (P-37) . This indicated that the 37 Ag may represent a marker of resistance
to S . mansoni and may be a target of protective immunity. We report here on the
cloning ofthecDNA for this antigen and on the homology it shares with a glycolytic
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enzyme that is highly conserved in evolution. The hypothesis is discussed that genetic
restriction of the immune response to these proteins might occur in heterogeneous
human populations because of the limited number of epitopes borne by these host-
like proteins.
Chemicals, Enzymes, and Reagents
Materials and Methods
Modified Eagle's medium (MEM), Hepes, penicillin, and streptomycin were purchased
from Gibco Laboratories (Paisley, Scotland); n-octylglucoside (1-0-n-octyl-S-O-glucopyrano-
side), pepstatin, PMSF, a2-macroglobulin, leupeptin, dithiothreitol, and cesium chloride
were from Boehringer Mannheim Biochemicals (Mannheim, FRG); aprotinin, N-lauroyl-
sarcosine, and Triton X-100 were from Sigma Chemical Co. (St. Louis, MO); DMSO was
from Merck Biochemica (Darmstadt, FRG). Glyoxal technical was purchased from BDH
Chemicals Ltd. (Poole, England) and deionized on analytical grademixed bed resin AG501-
X8 from Bio-Rad Laboratories (Richmond, CA). Protein A-Sepharose CL-4Bwas from Phar-
macia LKB Biotechnology AB (Uppsala, Sweden). SDS was from Fluka Chemie AG (Buchs,
Switzerland). CFA and IFA were from Difco Laboratories Inc. (Detroit, MI). Rabbit reticulo-
cyte lysates for in vitro translation, restriction enzymes, and exonuclease III and VII were
from BRL Life Technologies, Inc. (Clergy Pontoise, France). DNA sequencingwas performed
using a sequenase kit (United States Biochemical Corp., Cleveland, OH). Alkaline phosphatase-
conjugated anti-IgG antibodies were purchased from Promega Biotec (Madison, WI). FITC-
conjugated IgG anti-rabbit or anti-mouse Igwere from Institut Pasteur Production(Marnes-
la-Coquette, France). x-ray films were from Fuji Photo Film Co., Ltd. (Japan).
Parasitologic Methods
The Puerto Rican strain of S. mansoni used in this study was obtained from the Harvard
Medical School colony (Boston, MA), and was maintained by passage through CBA/J mice
and Biomphalaria glabrata snails. Schistosomula were prepared by the method of Ramalho Pinto,
as modified by Lazdins et al. (15), and cultured for 3-4 h at 37°C in MEM supplemented
with 10 mM Hepes, 100 IU/ml penicillin, and 100 t~g/ml streptomycin.
Adult schistosomes were recovered from the hepatic portal vein of6-8-wk-oldinfected mice
by perfusion (16). The collected worms were washed several times in MEM, Hepes, peni-
cillin, and streptomycin medium, and were immediately frozen in liquid nitrogen.
Immunologic and Biochemical Procedures
Tegument Extraction.
￿
Schistosomular tegument was extracted by resuspending schistoso-
mula (105/ml) in 117o n-octylglucoside containing 10 mM phosphate buffer (pH 7 .1), 4 mM
MgC12, 140 mM NaCl, to which the following protease inhibitors were added just before
use: 50 pM PMSF, 50 gg/ml aprotinin, 1 pM pepstatin, 20 Kg/ml leupeptin, and 10 14g/ml
a2-macroglobulin. After 15 min at 4°C in the extraction solution, schistosomula bodies were
pelleted (800 g, 3 min, 4°C) and the supernatants were centrifuged at 105 g for 35 min at
4°C. Then the supernatants of ultracentrifugation were stored at -70°C until use.
Preparation ofP-37.
￿
Schistosomular tegumental membrane extracts were heated (100°C,
3 min) in sample buffer (1% SDS [wt/vol] 50 mM Tris HCI, pH 8, 5% 2-ME, 1 mM EDTA,
10% [vol/vol] glycerol) and subjected to electrophoresis on a 7.5% SDS polyacrylamide gel.
The band ofinterest was identifiedas described (10) and cut off the gel, then, P-37 was eluted
according to Hunkapiller et al. (17) with few modifications (10). This method allowed the
preparation of0.1-0.3 wg of P-37 from the membrane extracts of 103 schistosomula. The elec-
troeluted Ag yielded one sharp band after rerunning on polyacrylamide gels and staining
by the silver stain method (18).
Preparation of the Anti-R37 Rabbit and Mouse Antisera.
￿
A rabbit and several BALB/c mice
were primed with 500 1Ag (rabbit) or 50 Kg (mice) of the electro-eluted P-37 preparation in
CFA and boosted twice at 2-mo intervals with the same amount of material in IFA. Animals
were bled beginning 3 wk after the last injection. The immune sera reacted with one proteinGOUDOTCROZEL ET AL.
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band (37 kD)on Western blotsofschistosomular membrane extracts that wasundistinguish-
able from the P-37 protein band identified by sera from subjects with low susceptibility to
infectionby S. mansoni(data_ not shown). Control sera were prepared by immunizing animals
with the adjuvant only.
HumanSera.
￿
The immune human sera (IHS) were from subjects whose susceptibility to
infection by S. mansoni was determined in a previous study (10).
Immuno ,fluorescence Studies.
￿
Fresh schistosomulawere washed threetimesin cold MEM sup-
plementedwith 10 mM Hepes, 10 IU/ml penicillin, and 100 UG/ml streptomycin, and were
reactedat 4°C for 2 h with a 1 :200 (rabbit serum) or 1:50 (mouse serum) dilution ofanti-P
37, anti-rP-37 or control antisera. Then, larvae were washed threetimes in cold MEM/peni-
cillin and streptomycin (PS)/Hepes medium and reacted for a further 1-h incubation period
with a 1:50dilution ofFITC-conjugated IgG anti-rabbit or anti-mouse Ig. Thelarvae were
then washed three times in cold MEM/PStHepes medium and examined under a fluores-
cence microscope (E. Leitz, Inc., Wetzlar, FRG) at a magnification of 400.
Immunoprecipitation of In Vitro Translation Products.
￿
"S-labeled in vitro translation products
were precleared by incubation for 30 min at 4°C with protein A-coupled Sepharose beads
in buffer A (10 mM Na2PO4, pH 7, 100 mM NaCl, 1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% SDS, 1 mg/ml BSA). Then, samples were centrifuged (15 min, 12,000 g) and
supernatants reacted for2 hat room temperature with 10 pl (rabbit) or 5tcl(human)immune
sera. Then, 1 vol of protein A-Sepharose 50% (vol/vol) was added and the incubation con-
tinued for 1 h at 4°C. Then, beads were washed four times in buffer A and resuspended
in sample buffer, heated (5 min, 100°C), centrifuged (3 min, 12,000g), and the supernatants
were analyzed by SDS-PAGE and fluorography.
DNA and RNA Methods
DNA andRNA Isolation.
￿
Genomic DNA was isolated from cercarial nuclei (19). 5 x 104
frozen cercariae were homogenized in 4 ml of ice-cold buffer B (10 mM Tris-HCI, pH 7.4,
60 mM NaCl, 0.15 mM spermine,0.15 mM spermidine, 10 mM EDTA, 0.5% Triton X-100).
The mixture wascentrifuged 20 s at 1,000g. This firstpellet wasdiscarded andthe superna-
tant centrifuged 7 min at 6,000g. This second pellet contained thenuclei, it was resuspended
in buffer Bsupplemented with 2% N-lauroylsarcosine, and incubated 15 minat 55 °C. Then,
1.273 (wt/wt) (p = 1.7) of solid cesium chloride was added, followed by ultracentrifugation
for 50 h at 45,000 rpm (VTI 65; Beckman Instruments, Inc., Fullerton, CA). The DNA
band was recovered and dialyzed against Tris-EDTA, pH 7.4. RNA was isolated from adult
worms by the guanidinium isothiocyanate method (20).
cDNA Clones Isolation.
￿
ThecDNA library wasconstructed in thebacteriophage Xgtll using
poly(A)' RNA isolated from adult worms (21). Recombinants were plated at high density
on Escherichia coli Y.1090 under isopropyl/3-n-thiogalactopyranosid (IPTG) induction condi-
tions and replicates were screened using the rabbit antiserum raised against the 37-kD an-
tigen and either '25I-labeled protein A or alkaline phosphatase-conjugated anti-IgG anti-
bodies. Plaques that were clearly positives were transferred to fresh agar plates andscreened
with the same reagents. This procedure was repeated until 100% of the plaques were found
to be positive. ThesixcDNA clones that were isolated by this procedure also reacted strongly
with the anti-P-37 mouse antisera. To further evaluate whether the inserts encoded distinct
or related proteins, one cDNA insert was prepared following the procedure of Yamamoto
(22), 12p_labeled by the random priming method (23), and hybridized with replicas of the
positive clones. At astringency of0.1 x saline sodium citrate(SSC) (1 x SSC is 150mM NaCl,
15 mM sodium citrate), at 55°C, the probe hybridized with the six cDNA clones while it
did not with irrelevant DNA control. Then, two cDNA clones that contained inserts of 0.7
and 1.1 kb were subclonedin the Bluescript vector (Stratagene, SanDiego, CA)forthe Northern
and Southern blotting experiments and for cDNA sequencing.
DNA Sequencing.
￿
The 1.1-kb cDNA insert was sequenced using the dideoxy chain termi-
nation method (24) with Sequenase. Sequence data were confirmed in both orientations; one
strand was sequencedon deletedExoIII-ExoVIIBluescript templates(25), andtheopposite
strand on restriction fragments subcloned in M13 bacteriophage (26).
Northern Blot. RNA samples were treated in 1 M glyoxal, 50% DMSO, 10 mM2068 MOLECULAR MIMICRY AND SUSCEPTIBILITY TO SCHISTOSOMIASIS
Na2HP04, pH 7, for 1 h at 50°C, and run on a 1.1% agarose gel (27). Then, the gel was
blotted against Hybond N (Amersham, les Ulis, France) nylon membrane overnight in 20 x
SSC. The membranes were then baked 2 h at 80°C to remove glyoxal and were reacte4 with
a 12P-labeled cDNA probe overnight at 37 °C in 50% formamide. Washes were proceeded
at 55°C to a stringency of 0.5 x SSC. Then, membranes were allowed to dry and were au-
toradiographed at -70°C with an intensifying screen.
Genomic Southern Blot.
￿
Genomic DNA (5 kg) was digested with restriction endonucleases
as described in Fig. 5 and separated on 1% agarose gel. DNA was then acid depurinated,
denaturated, transferred to Nylon membrane (Gene Screen Plus; New England Nuclear,
Boston, MA) overnight in denaturating buffer (0.5 M NaOH, 1.5 MNaCl), and neutralized
(28). The membrane was then reacted with a 12P-labeled cDNA probe overnight at 65°C
in hybridization buffer, and washed at 65°C to a stringency of 0.1 x SSC. The membrane,
allowed to dry, was then autoradiographed at -70°C with an intensifying screen.
Hybrid Selection.
￿
mRNA were selected by hybridization of 10 ,ug of poly(A)' adult worm
RNA to 70 hg of linearized Bluescript vector containing the cloned cDNA and immobilized
on cellulose powder. We essentially followed the protocol of Seed (29), except for the use of
cellulose powder (Ce 180; Schleicher & Schuell, Inc., Dassel, FRG) instead of Whatman 50
paper. The activated cellulose powder was a generous gift of Dr. Tomaso Meo (Pasteur Insti-
tute, Paris). Selected mRNAs were translated in the rabbit reticulocyte lysates and the trans-
lation products were analyzed on a l0olo SDSJacrylamide gel.
Results
Cloning of P-37 Encoding cDNAs.
￿
The anti-serum used for the screening of the
cDNA library was prepared by immunizing a rabbit with electroeluted preparations
ofP-37. This antiserum yielded one 37-kD band on Western blots of schistosomular
membrane extracts and it produced a strong membrane fluorescence when reacted
with fresh living larvae. This serum, and sera from subjects with low susceptibility
to infection, precipitated the same 37-kD polypeptide from the in vitro translated
products of schistosome RNA (Fig. 1). The sera also precipitated a 32-kD polypep-
tide that probably corresponds to an internal initiation of the translation of P-37
RNA. These observations, altogether, indicated that the rabbit antiserum reacted
with P-37 denaturated polypeptide chain and was suitable for the screening of an
expression library.
With this serum, six independent clones were selected out of 2 x 105 plaques.
These clones were also positive with a mouse antiserum raised against P-37. cDNA
inserts from the six clones hybridized to each other in high stringency conditions,
indicating that they encoded related polypeptides. Two cDNA clones selected for
further work encoded a protein that had an apparent M, of 153 kD (Fig. 2).
Rabbit antibodies, affinity purified on this recombinant protein, reacted with P-37
on blots of schistosomular membrane extracts (data not shown). Then, the cloned
cDNA was inserted in the pJF118EH vector (30) that allowed (in the presence of
IPTG) the production of a 37-kD recombinant protein that was selectively recog-
nized by the anti-P37 rabbit serum and by two IHS that had been selected for their
high reactivity to P-37 (Fig. 2 A). The immunoreactive recombinant protein was
absent from the bacteria that were cultured without IPTG. The reactivity of 18 im-
mune human sera for this recombinant protein was also tested (as illustrated with
10 sera in Fig. 2). 11 ofthese 18 sera reacted with P-37 (in schistosomular membrane
extracts), 6 of these 11 sera reacted with the recombinant protein (IHS 1, 3, 4, 5,
6, 7), and five sera (that exhibited a low reactivity for P-37) did not identify the
recombinant protein, probably because the amount of recombinant protein on theGOUDOTCROZEL ET AL.
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FIGURE 1 .
￿
Serum from a resistant subject (IHS) and the
rabbit anti-P-37 antiserum (immune rabbit serum [IRS)
precipitate the same 37-kD in vitro translated polypeptide
of schistosome RNA. (Lanes 1-3) Precipitates from three
successive rounds of precipitation with IHS . (Lanes 5and
6) Polypeptides precipitated by IRSandNRS, respectively.
(Lane 4) IRS reacted with the supernatant of the third
precipitation of in vitro translation products by IHS .
blot was farlowerthan that ofP-37 . Seven sera reacted with neitherone (i.e., IHS-2) .
Finally, the cloned cDNA was coupled to a cellulose matrix and used to purify its
transcript from total schistosome mRNA by the method of hybrid selection . The
hybrid-selectedRNA encodeda 37-kDpolypeptide that was selectively precipitated
by the rabbit anti-P37 serum and by several IHS containing antibody against P-37
(Fig . 3) . Altogether, these observations indicated that the recombinant polypeptide
encoded by the cloned cDNA was the P-37 Ag identified in a previous study.
Gene andmRNA Encoding P-37 .
￿
The inserts hybridized with a single 1.2-kb spe-
cies in Northern blots of schistosomeRNA (Fig . 4) . Probing ofgenomic Southern
blots of restricted cercarial DNA with the cDNA insert yielded single bands that,
dependingon the enzyme, varied in size from 3 to 11 kb (Fig . 5) . Thus, the results
of Northern and Southern blots are consistent with a single copy gene encoding a
single mRNA species.
Nucleotide Sequence of ClonedcDNA .
￿
Nucleotide sequencing of an 1,103-bp cDNA
insert revealed a 1,017-bp open readingframe that terminates with three stop codons
and is flanked by 5' and 3' untranslated regions of 13 and 73 bp, respectively, and
contains anAATAAA poly(A)addition signal in position 1070 (Fig. 6) . The 338-amino2070 MOLECULAR MIMICRY AND SUSCEPTIBILITY TO SCHISTOSOMIASIS
FIGURE 2 .
￿
Reactivity of the anti-P37 IHS and IRS for the recombinant protein produced in
pJF vector . (A) Reactivity of two IHS and of the anti-P-37 rabbit sera for detergent extracts of
pJF-transformedE . coli that were cultured with (left) or without (right) IPTG . (B) Reactivity of
eight IHS for P-37 (in schistosomular membrane extracts) and for the recombinant protein (in
pJF extracts) . The reactivity ofthe sera (dilution 1:50 to 1 :200) for the recombinant protein and
for P-37 was tested by immunoblotting using the equivalent of200 Al of bacterial culture or of
5-10 x 103 schistosomula per lanes .
FIGURE 3 .
￿
Thecloned cDNA hybridizes with a worm mRNA that encodes a 37-kD polypep-
tide precipitable bysera from resistanthumans . (A) Cell-free translation ofmRNA hybridselected
by thecDNA subcloned in Bluescript (lane 1), or endogenous background in the absence ofadded
RNA (lane 2). (B) Immunoprecipitation of cell-free translation products of the hybrid-selected
mRNA (lanes 1, 3, 5, and 7) by the anti-37-kD IRS (lane 2) and by three sera from resistant
humans (lanes 4, 6, and 8) . The 45-kDband is also observed when the reticulocyte lysate is in-
cubated with 35S-methionine in the absence of addedRNA.GOUDOTCROZEL ET AL .
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FIGURE 4 .
￿
Northern blot analysisoftotal schis-
tosome RNA probed with P-37 cDNA .
acid-encoded polypeptide has a predicted molecular mass of 36.4 kD and contains
one potential N-glycosylation site (Asn-Ala-Ser) in position 150-152 . Codon usage
is nonrandom, A andT beingmore frequently used, except forlysine and asparagine,
as previously reported for other schistosome proteins (31) . Consequently, thecDNA
has a 57.3% adenosine/thymidinecontent. The predicted amino acid sequence con-
tains two clusters of hydrophobic residues (LeuVal-Leuand Ala-Ala-Phe-Leu) near
the NH2 terminus that may represent a signal peptide for the translocation of the
protein through themembrane. Similar signal peptides have been reported forhuman
preprolactin and E . coli prepenicillinase (32) .
P-37 ShowsHigh Homology with the Glyceraldehyde-3-P-dehydrogmase(3-GAPDH) .
￿
Com-
parison of the amino acid sequence of the recombinant protein (rP-37) with the se-
quence of other proteins compiled in the Microgenie program revealed 75.3 and
72.5% positional identity with chicken and human 3-GAPDH, respectively (Fig .
6), and 85 and 83.2% when accounting for conservative substitutions. If P-37 was
afunctional enzyme, the amino acids involved in the interactions between GAPDH,
GAP (substrate) andNAD(coenzyme), wouldbe conserved. Theseamino acidshave
been identified on a Bacillus stearothermophilus enzyme using mutants and cristallog-
raphy (33, 34) . 12 were shown to play a critical role in the cayalytic reaction, in-
cluding an oxido reduction that yields an acyl-enzyme and NADH, followed by a
phosphorylation in the presence ofNADthat leadsto 1,3diphosphoglycerate . These
amino acids were involved either in charge transfer, in the binding ofNAD, of the
inorganic phosphate or ofGAP, or contributed to the specificity of the enzyme for2072 MOLECULAR MIMICRY AND SUSCEPTIBILITY TO SCHISTOSOMIASIS
FIGURE 5 .
￿
Southern blot analysis of cercarial genomic DNA digested
with restriction enzymes as indicated, and probed with P-37 cDNA .
the D orientation of GAP (Table I) . All these amino acids are conserved on P-37
(after proper alignment ofthe sequences) ; three amino acids, underscored in Table
1, were shifted by one residue as compared with their positions in the bacterial en-
zyme. This indicates that P-37 probably has a functional catalytic site .
Antibodies to the Recombinant Protein Identify P-37 on the Larvae .
￿
To further confirm
the presence of P-37 on the parasite, CBA/J mice were immunized with the recom-
binant protein in adjuvant and their sera were tested by immunofluorescence on
intact living larvae.A stronghomogeneous fluorescence associated with the surface
of the parasite was observed (Fig. 7) . Control sera from mice immunized with the
adjuvant only or sera containing antibodies directed against the (3-galactosidase were
negative in this assay . Since schistosomula were prepared by mechanical methods
in protein-free chemically defined medium, theprotein identified by the antibodies
was from parasite origin and could not have been acquired from a host .
Discussion
In aprevious study (10), we have shown that susceptibility to infection by S . man-
soni varies markedly among residents ofendemic area ; certain subjects resist infec-
tions or maintain low levels of infections for long periods of time, while others are
reinfected shortly after parasitologicalcureand developheavy infections . This latterSCHISTOSOME Ssr37 : 1
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FIGURE 6.
￿
Nucleotide andpredicted
amino acid sequence of P-37 cDNA
compared with chicken and human
3-GAPDHaminoacid sequences. The
nucleotides are numbered in the 5' to
3' direction, starting with the first
nucleotide in thecodoncorresponding
to the putative NH2-terminal residue
in the protein. Gaps were inserted in
sequencesto achieve maximum align-
ment. Identical aminoacidsareboxed.
These sequence data have been sub-
mitted to the EMBLJGenBank Data
Libraries.
group runs ahigh risk of severe disease(11-15) and is the principal reservoirof para-
sites in the endemic area. We (10) have attempted to determine the causes of their
higher susceptibility. Analysis of their antibody response to S. mansoni revealed that
their sera failed to react with a 37-kD larval surface protein that is a major antigen
for antibodies in the sera of the most resistant subjects (10). The cDNA encoding2074 MOLECULAR MIMICRY AND SUSCEPTIBILITY TO SCHISTOSOMIASIS
TABLE I
Amino Acid Residues Essential to GAPDH Enzymatic Activity:
Comparison of P-37 with B . stearothermophilus GAPDH
this antigen has now been cloned; its amino acid sequence and its nature have been
determined.
A number of observations confirmed that the cloned cDNA encodes P-37 : first,
sera from the rabbit and mice immunized with P-37 reacted with the recombinant
protein on immunoblots while control sera failed to do so; conversely rabbit anti-
body, immunopurified on the fusion protein, selectively bound to P-37 on blots of
larval membrane extracts. Second, all six cDNA clones identified by the rabbit and
mouse immune sera crosshybridized, indicating that they encoded related proteins;
two of these cDNA clones were shown, by hybrid selection and in vitro translation,
to encode a 37-kD polypeptide that was precipitable by anti-P-37 rabbit serum and
by sera from several resistant subjects. Third, the 37-kD recombinant protein pro-
duced in the pJF vector was identified by all six human immune sera that reacted
strongly with P-37 on immunoblots; conversely, all seven immune human sera that
did not react with P-37 failed to react with the recombinant protein. Fourth, anti-
bodies raised in mice against the recombinant protein, reacted with the surface of
the parasite, as did anti-P-37 antibodies.
The observation that certain immune human sera reacting with P-37 failed to
identify the recombinant protein can not be taken as an indication for more than
one P-37 protein or for the absence of certain antigenic determinants on the recom-
binant product, because the amount of recombinant protein on the blot was prob-
ably too low (at least 10-fold lower than P-37) to allow the detection of the protein
by these sera that exhibited a low reactivity toward P-37.
The amino acid sequence of P-37 does not indicate how this protein associates
with the parasite tegument because the sequence of the recombinant polypeptide
contains neitheratypicaltransmembrane domain nor the terminal hydrophobic tail
Amino
acid
B.
stearothermophilus
(3-GAPDH)
S.
mansoni
(P-37)
Charge transfer cys 149 153
tyr 317 321
Nucleophilic functions cys 149 153
his 176 180
NAD binding site asn 313 317
asp 32 35
Inorganic phosphate binding site ser 148 152
thr 150 154
arg 195 198
thr 208 212
GAP phosphate binding site thr 179 183
arg 231 236
D specificity of GAPDH in C2 position ser 148 152GOUDOTCROZEL ET AL .
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FIGURE 7 . Antibodies to the
recombinant proteinlocateP-37
on the larvae. Fresh intactlarvae
were reacted either with the
rabbit sera used for the cloning
or with sera from mice immun-
ized with the recombinant pro-
tein in CFA . Surface-bound
antibodies were revealed with
FITC-conjugated rabbit anti-
mouse or goat anti-rabbit IgG .
(A) Anti-P-37 rabbit serum; (B)
anti-recombinant proteinmouse
serum 1; (C) control mouse
serum ; (D) anti-recombinant
protein mouse serum 2 .
that is a common feature of most proteins anchored on a phosphatidylinositol . Nor
have we found evidence for distinct mRNAs encoding a putative cytosolic protein
and the membrane antigen . Thus, we have no evidence indicating that P-37 is in-
serted in or covalently linked to the lipid bilayer of the parasite tegument .
Since most amino acid residues involved in the enzymatic activity are conserved
in the cloned protein, P-37 is likely to possess an intact enzymatic site ; indeed, when
the substrates of the enzymatic reaction were provided, GAPDH activity was de-
tected associated with living and healthy schistosomula, while no such activity was
detected in parasite supernatant fluids, indicating that the detected activity wasprob-
ably not released by damaged organisms (A . Bourgois, unpublished data) . Thus,
two glycolytic enzymes have been located on the surface of schistosomula sinceHam
andcollaborators (34a) have observed that the 28-kDtarget oftheirprotectivemouse
mAb is a surface-located triose-phosphate isomerase that is located on the larvae.
Schistosome ingest large quantities of glucose, asmuch as 26% of their dry body
weight per hour, that they ferment into lactic acid (35-37) . Since they depend al-2076 MOLECULAR MIMICRY AND SUSCEPTIBILITY TO SCHISTOSOMIASIS
most exclusively on glycolysis fortheir energy, GAPDH is certainly critical to para-
site survival. The function of the surface-located enzyme is, however, not clear. So
far there is no evidence indicating that it plays a metabolic role at the surface since
it would have to be associated with other glycolytic enzymes to perform its catalytic
activity.
The observation that P-37 is homologous to a protein that is highly conserved
in evolution adds to the reports of others that several major targets of immunity
on schistosomes are proteins sharinglargeregions ofhomology with thecorresponding
host proteins, such as the heat shock proteins (38, 39), glutathione-S-transferase (40,
41), myosin (42), and a serine protease (43). It is not unexpected to find host-like
proteins on the surface of sophisticated parasites since it has been hypothesized for
a long time that such determinants would allow parasites to escape recognition by
the host immune system (43-45). The experimental facts, however, do notfulfill the
predictions ofthe mimicry theory since most of these proteins are immuno-dominant
antigens on theparasite and are majortargets of immunity (10, 39-46). On theother
hand, theT cell response to these antigens is probably directed to a very lownumber
of epitopes: first, because only a small number of epitopes are recognized by T cells
on any protein (47-49); and second, because the large homologies between these
proteins and host molecules reduce even further the number of possible T cell epi-
topes. Consequently, the human T cell response against these proteins is likely to
be very sensitive to genetic restrictions, increasing the probability for the parasite
to infect nonresponder individuals. Such genetic restriction ofthe immune response
to these host-likeparasite antigens may account forthe high susceptibility of certain
subjects and may allow parasite transmission in a population that, for themost part,
has developed efficient although incomplete immunity. One may speculate that this
process fits well with the needs of parasites for survival since the parasites would
be maintained mostly by passage through the most susceptible subjects without
markedly affecting the remaining population. The most susceptible group, an im-
portant parasite reservoir, would not be rendered extinct by the disease if heterozy-
gotes carrying the allele(s) for susceptibility did not develop a severe disease. Since
P-37 has been cloned and can be produced in large quantity, it is now possible to
determine whethergenetic restriction affects its immunogenicity in human subjects.
Our recent report on a major gene controlling human susceptibility to infection by
S. mansoni lays the ground for such studies (Abel, L., and A. Dessein, unpublished
results).
Finally, these findings also raise the possibility that these antigens may, in certain
subjects, stimulate the production of autoantibodies (50) if parasite-specific regions
on those antigens could play the role of carriers for an antibody response toward
the conserved regions.
Summary
Schistosomiasis, due to Schistosoma mansoni, is a major health problem in many
subtropical countries, and major efforts are being made to define a vaccine. In this
regard, we have reported that sera from subjects with low susceptibility to infection
by S. mansoni react with a major larval surface antigen (P-37), having an apparent
molecular mass of 37 kD, against which sera of susceptible individuals show little
reactivity.We have now cloned the cDNA for this antigen by screening a schistosome cDNA
expression library with antibodies against the purified protein. The selected cDNAs
encode a protein that is specifically identified by immune human sera containing
antibodies against P-37, while sera exhibiting low or no reactivity toward P-37 fail
to recognize the recombinant protein. The cloned cDNAs hybridize with a 1.2-kb
RNA that is the transcript of a single copy gene. This RNA directs the synthesis
of a 36.5-kD polypeptide that is precipitated by sera from the most resistant sub-
jects. The amino acid sequence of the encoded polypeptide shows homology with
the glycolytic enzyme Glyceraldehyde-3P-dehydrogenase (72 .5% of positional iden-
tity with human Glyceraldehyde-3P-dehydrogenase). Antibodies against the recom-
binant protein identified P-37 on the larva.
These findings, together with other reports, indicate that a number of conserved
proteins may be major targets ofhost-protective immunity against S mansont. The
hypothesis is discussed that genetic restriction of the immune response to these an-
tigens may occur in heterogeneous human populations because ofthe limited number
ofT cell epitopes carried by thesehost-like proteins. Such genetic effects might allow
parasite transmission through nonresponder (susceptible) individuals. This hypoth-
esis and the protective properties of P-37 can now be tested using the recombinant
protein and synthetic peptides derived from selected regions ofthe polypeptide chain.
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